BHC - Bausch Health Companies Inc.

QQQ $ 432.54 $ -0.62 (-0.14 %)

DIA $ 383.18 $ -0.01 (-0 %)

SPY $ 509.92 $ -0.34 (-0.07 %)

TLT $ 88.80 $ 0.14 (0.16 %)

GLD $ 216.76 $ 0.13 (0.06 %)

Previous Close

$ 8.71

Open

$ 8.77

Bid

$ 8.76 x 100

Ask

$ 8.78 x 200

Day's Range

$ 8.76 - $ 8.86

52 Week Range

$ 5.57 - $ 11.46

Volume

2,082,642

Average Volume

Market Cap

3.18B

Beta (5Y Monthly)

$ 1.39

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-22-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-04-2023	03-31-2023	10-Q
5	02-23-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	02-23-2022	12-31-2021	10-K
10	11-02-2021	09-30-2021	10-Q
11	08-03-2021	06-30-2021	10-Q
12	05-04-2021	03-31-2021	10-Q
13	02-24-2021	12-31-2020	10-K
14	11-03-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	02-19-2020	12-31-2019	10-K
18	11-04-2019	09-30-2019	10-Q
19	08-06-2019	06-30-2019	10-Q
20	05-06-2019	03-31-2019	10-Q
21	02-20-2019	12-31-2018	10-K
22	11-06-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-08-2018	03-31-2018	10-Q
25	02-28-2018	12-31-2017	10-K
26	11-07-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	03-01-2017	12-31-2016	10-K
30	11-09-2016	09-30-2016	10-Q
31	08-09-2016	06-30-2016	10-Q
32	06-07-2016	03-31-2016	10-Q
33	04-29-2016	12-31-2015	10-K
34	10-26-2015	09-30-2015	10-Q
35	07-28-2015	06-30-2015	10-Q
36	04-30-2015	03-31-2015	10-Q
37	02-25-2015	12-31-2014	10-K
38	10-24-2014	09-30-2014	10-Q
39	08-01-2014	06-30-2014	10-Q
40	05-09-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

RBC Capital Maintains Sector Perform on Ba...
04/23/2024 15:44:37

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price ta...

RBC Capital Reiterates Sector Perform on B...
04/12/2024 14:15:57

RBC Capital analyst Douglas Miehm reiterates Bausch Health Companies (NYSE:BHC) with a Sector Perform and maintains $12 pric...

U.S. Appeals Court Says Bausch Can Block A...
04/11/2024 15:50:15

- Reuters Citing U.S. Appeals Court

Bausch Health Companies Appeals Court Ruli...
04/11/2024 14:59:30

https://storage.courtlistener.com/recap/gov.uscourts.cafc.19114/gov.uscourts.cafc.19114.71.0.pdf

Acne Vulgaris Treatment PrARAZLO Now Avail...
04/11/2024 12:04:37

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescrip...

Bausch Health Announces Patent Lawsuit Aga...
04/05/2024 22:27:59

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) along with its gastroenterology business, Salix Pharmaceuticals, Inc., announc...

RBC Capital Maintains Sector Perform on Ba...
04/05/2024 11:21:10

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price ta...

Bausch Health, Canada Announces First Pub...
04/03/2024 12:08:22

Salix Pharmaceuticals Announces Phase 2 In...
03/06/2024 13:05:26

RBC Capital Maintains Sector Perform Ratin...
02/23/2024 17:00:08

RBC Capital Maintains Sector Perform on Ba...
02/23/2024 15:29:57

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price ta...

Bausch Health Companies Forecasts 2024 Rev...
02/22/2024 12:15:20

Bausch Health Companies Q4 Sales $2.41B Be...
02/22/2024 12:12:52

Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.41 billion which beat the analyst consensus estimate of $2.30...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Preview: Bausch Health Companies's Earnings
02/21/2024 15:01:44

a-toxic-byproduct-of-an-imperfect-higher-education-system--famous-short-seller-known-as-the-assassin-strikes-her-newest-target

A 'Toxic Byproduct of an Imperfect Higher ...
02/08/2024 13:59:14

CABTREO(TM) (Clindamycin Phosphate, Adapal...
01/30/2024 13:06:11

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. la...

Solta Medical's Thermage FLX And TR-4 Retu...
01/18/2024 13:06:05

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and Solta Medical, a global leader in the medical aesthetics market, today ann...

Bausch Health Announces Topline Results Fr...
12/21/2023 12:04:51

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced positive to...

Bausch Health, Canada, Part Of Bausch Heal...
12/18/2023 13:06:35

DUOBRII is already available as a benefit on most other public drug plans in the rest of Canada, including the federal governme...